UCL News


Dismay as Alzheimer's drug fails in clinical trials

23 November 2016

Professor Rob Howard (UCL Psychiatry), Professor John Hardy and Professor Nick Fox (UCL Institute of Neurology) comment on the failure in late-phase effectiveness trials of solanezumab, a drug which had shown promise for treating Alzheimer's disease in early tests. Read: The Guardian, More: Reuters, BBC NewsDaily Mail